about
Topical treatments for chronic plaque psoriasisTopical treatments for chronic plaque psoriasisExtending psychosocial assessment of patients with psoriasis in the UK, using a self-rateds, web-based survey.The impact of disease-related impairments on disability and health-related quality of life: a systematic review.Targeting of human interleukin-12B by small hairpin RNAs in xenografted psoriatic skin.Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis.European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey.Health-related quality of life in patients with primary cutaneous amyloidosis.Quality of life in dermatomyositis.Ciclosporin in psoriasis clinical practice: an international consensus statement.Psychiatric morbidity in psoriasis: a review.Topical Turmeric Microemulgel in the Management of Plaque Psoriasis; A Clinical Evaluation.Physical and mental impact of psoriasis severity as measured by the compact Short Form-12 Health Survey (SF-12) quality of life tool.Disease Severity, Quality of Life, and Psychiatric Morbidity in Patients With Psoriasis With Reference to Sociodemographic, Lifestyle, and Clinical Variables: A Prospective, Cross-Sectional Study From Lahore, Pakistan.Depression and Anxiety Disorders among Patients with Psoriasis: A Hospital-Based Case-Control Study.Current severe psoriasis and the rule of tens.Nail psoriasis as a severity indicator: results from the PsoReal study.Reliability and validity of the Chinese version of the Psoriasis Disability Index (PDI) in Chinese patients with psoriasisThe clinical benefit of moisturizers.Quality of life and psychosocial aspects in Greek patients with psoriasis: a cross-sectional study.Clinical, Quality of Life, Patient Adherence, and Safety Outcomes of Short-Course (12 Weeks) Treatment with Cyclosporine in Patients with Severe Psoriasis (the Practice Study).Regulation of cytokines by small RNAs during skin inflammation.Adherence in the treatment of psoriasis: a systematic review.Cost-efficacy comparison of biological therapies for patients with moderate to severe psoriasis in Japan.Quality of life in psoriasis patients.Psoriasis and psycho-dermatology.Barriers to guideline-compliant psoriasis care: analyses and concepts.Sleep Quality and its Association with Disease Severity in Psoriasis.Education to improve quality of life of people with chronic inflammatory skin conditions: a systematic review of the evidence.HLA-Cw6 homozygosity in plaque psoriasis is associated with streptococcal throat infections and pronounced improvement after tonsillectomy: A prospective case series.Quality of life and cost of illness in patients with psoriasis in Malaysia: a multicenter study.Body image altered by psoriasis. A study based on individual interviews and a model for body image.Lifestyle of Nordic people with psoriasis.SF-36 healty survey on psoriasis quality-of-life: a study of 414 Taiwanese patients.Impact of functional pruritus compared with mild psoriasis on quality of life: a cross-sectional questionnaire study in Turkey.Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomes.Identification of psoriatic patients at risk of high quality of life impairment.Analysis of three outcome measures in moderate to severe psoriasis: a registry-based study of 2450 patients.Dyadic adjustment, family coping, body image, quality of life and psychological morbidity in patients with psoriasis and their partners.Quality of life impairment and psychological distress in elderly patients with psoriasis.
P2860
Q24198258-3AE62AB0-FFCA-4CBE-B10D-D2AAC61D4A34Q24241239-22D0E1A8-068F-49B6-9165-9BCEA0DFD5D0Q30485712-E0B52DA4-16B6-407B-86F4-1BF9294F6275Q33288190-1B4CEBEB-6C07-4F5C-B0AF-BB57A9C02B6DQ33830208-9B3336ED-0C73-408C-A3EE-3466EB1E5A3EQ34564453-AE0747D4-2608-4C6C-BFD0-3537B3E20205Q34570738-C8DFF4EE-BF59-46D9-8A7A-81BD8BFE9342Q35208171-080BFB20-57FF-4219-8DF5-BED031BD11FEQ35293264-8B545447-3D23-41D8-AB37-213F9D9EA290Q35759170-AA5BB056-F70D-457E-8D62-E63BEAF2E653Q35834696-5CF9AEFC-033F-4FDB-A31D-19F239C094B9Q35897906-4E344294-881E-4C8B-A105-90E9DE088AEBQ36005460-4A96B643-D454-4771-A315-CCEC79D81B66Q36083240-101E9E9B-F46D-4D5E-A5BA-EF3D5F19526AQ36111248-3EFAF573-5D79-47DA-BA35-A5F13E65877CQ36124195-0300699B-A747-4A5B-AA3F-6ACF7EEB2E97Q36160601-E89376C9-1A95-4053-B2D3-43817043BB98Q36299430-C4E7DCC7-5B1F-4186-8A25-07F570ED1C6AQ36305888-A9CACE9E-95A8-48A5-B957-D94A3317E210Q36398293-9AA84FB3-0C5C-4096-BEE6-A8B236D73CF0Q36640532-C34E9D58-5225-4389-A015-D1910352692EQ37769284-B00EC087-8704-4C81-A3BD-0A1F3AEBDA04Q37901280-44028383-C60D-46FC-97C7-2DDEC6036545Q38013239-ADD55EF4-0587-4196-8A75-297892A256EDQ38211301-0F20D7C7-679B-4D30-8BCA-2EA9D4035B15Q38443811-1BC1D710-1230-4264-8D56-5D585684A14FQ38625686-B34BA275-9E64-4092-B36E-9E8EF3361C7AQ38714874-A3B44559-8C99-4AE1-81E7-0E3351D27EE8Q38718781-760981B3-725C-4008-9DA7-9894F2BB1A2DQ39494092-8F3782C6-A530-4249-8810-678B021F6EEFQ43446877-7A625947-BFCC-4B29-916C-A1989CD06ACBQ44243868-A92B9944-46E6-4F55-A6D4-881403BFFE43Q46470625-ECDF5D66-E42E-4D30-B818-C8489285B86DQ48053421-D490C3E3-0D09-444F-8EC6-DADB4363105CQ48079060-DD2D2751-799A-4D91-9DB4-506486CBD5E6Q48153959-BD0113AB-F1CB-477C-A298-DB9B9FFF2B7DQ48184749-32674875-BCB2-4520-A906-507B80E526FDQ48515876-4A5BFF55-C60E-4615-A867-9023CEC3CDC5Q48641201-14BA11A2-D87E-4C9C-93DF-7DB8B851350EQ50885734-08C5ED86-97F8-4AAD-94A6-25823A42EF0C
P2860
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Quality of life in 6497 Nordic patients with psoriasis.
@en
Quality of life in 6497 Nordic patients with psoriasis.
@nl
type
label
Quality of life in 6497 Nordic patients with psoriasis.
@en
Quality of life in 6497 Nordic patients with psoriasis.
@nl
prefLabel
Quality of life in 6497 Nordic patients with psoriasis.
@en
Quality of life in 6497 Nordic patients with psoriasis.
@nl
P2093
P2860
P1476
Quality of life in 6497 Nordic patients with psoriasis.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2133.2002.04742.X
P407
P577
2002-06-01T00:00:00Z